| Hugh Tilson | ||||
 | Adjunct Professor PH Leadership Program Senior Advisor Public Health Grand Rounds, NCIPH |
|
||
| Research activities Dr. Tilson received his MD from Washington University, and his MPH and DrPH from Harvard University. Dr. Tilson received his Bachelors from Reed College, his MD from Washington University School of Medicine, and his MPH and DrPH from Harvard School of Public Health. He has served as Director of North Carolinas Division of Health Services and was Vice President and Worldwide Director, Epidemiology, Surveillance & Policy Research at Glaxo Wellcome. |
| Key publications |
| Tilson, H, Kotsanos J (1997) Development of Performance Measures for Seven Chronic Diseases. The joint Commission Journal on Quality Improvement: vol.23, p.150-161. |
| Tilson, H, Novotny T (1997) Publishing while Practicing: A Five-Step Guide for Academic-Practice Partners" with TE Novotny et al.. American Journal of Preventive Medicine: vol.13, p.10-11. |
| Tilson, H (1996) Health Communities: New Partnerships for the Furture of Public Health (Preface). Institute of Medicine, National Academy Press |
| Tilson, H, Hickey A (1996) The Rheumatoid Arthritis Azathioprine Registry - an update". Advances in Anti-Rheumatic Therapy: vol.Chapter 9 |
| Tilson, H, Mauskoph J. (1996) Economic Impact of Treatment of HIV-Positive Pregnant Women and their newborns with Zidovudine: Implications for HIV Screening. JAMA: vol.276, p.132-138. |
